Description
SUBOXONE FOR BILOXI PHARMACY.
First action · last action
2010-11-29 · 2010-11-29
Transactions
1
First transaction's obligation
$4,619
Base + all options value (sum of deltas)
$4,619
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5790X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-11-29+$4,619= $4,619
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-11-29 | +$4,619 | $4,619 | SUBOXONE FOR BILOXI PHARMACY. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI VLCNBHCXCCJ9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0115 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36F79720D0156 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2020 |
| 36C24920N0359 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,849 | FY2020 |
| 36E79719A0011 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
| V797P2125D | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2012 |
| VA512P11706 | 512-BALTIMORE · 6515 · MED & SURGICAL INSTRUMENTS,EQ & SUP | $24,481 | FY2011 |
Other recipients under 6505 from 520-BILOXI (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0115 | ASTRAZENECA LIMITED PARTNERSHIP | 520-BILOXI | $7,335 | FY2013 |
| VA25613F0132 | LUNDBECK LLC | 520-BILOXI | $4,351 | FY2013 |
| VA25613F0083 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 520-BILOXI | $6,114 | FY2013 |
| VA25612F2422 | ASTRAZENECA LIMITED PARTNERSHIP | 520-BILOXI | $7,335 | FY2012 |
| VA25612F2354 | LUNDBECK LLC | 520-BILOXI | $4,351 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA520A10087_3600_V797P5790X_3600 · retrieved 2026-09-26.